Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells

  • Daniel Chauss (Geteilte/r Erstautor/in)
  • Tilo Freiwald (Geteilte/r Erstautor/in)
  • Reuben McGregor (Geteilte/r Erstautor/in)
  • Bingyu Yan (Geteilte/r Erstautor/in)
  • Luopin Wang
  • Estefania Nova-Lamperti
  • Dhaneshwar Kumar
  • Zonghao Zhang
  • Heather Teague
  • Erin E. West
  • Kevin M. Vannella
  • Marcos J. Ramos-Benitez
  • Jack Bibby
  • Audrey Kelly
  • Amna Malik
  • Alexandra F. Freeman
  • Daniella M. Schwartz
  • Didier Portilla
  • Daniel S. Chertow
  • Susan John
  • Paul Lavender
  • Claudia Kemper
  • Giovanna Lombardi
  • Nehal N. Mehta
  • Nichola Cooper
  • Michail S. Lionakis
  • Arian Laurence
  • Majid Kazemian (Geteilte/r Letztautor/in)
  • Behdad Afzali (Geteilte/r Letztautor/in)

Abstract

The molecular mechanisms governing orderly shutdown and retraction of CD4+ type 1 helper T (TH1) cell responses remain poorly understood. Here we show that complement triggers contraction of TH1 responses by inducing intrinsic expression of the vitamin D (VitD) receptor and the VitD-activating enzyme CYP27B1, permitting T cells to both activate and respond to VitD. VitD then initiated the transition from pro-inflammatory interferon-γ+ TH1 cells to suppressive interleukin-10+ cells. This process was primed by dynamic changes in the epigenetic landscape of CD4+ T cells, generating super-enhancers and recruiting several transcription factors, notably c-JUN, STAT3 and BACH2, which together with VitD receptor shaped the transcriptional response to VitD. Accordingly, VitD did not induce interleukin-10 expression in cells with dysfunctional BACH2 or STAT3. Bronchoalveolar lavage fluid CD4+ T cells of patients with COVID-19 were TH1-skewed and showed de-repression of genes downregulated by VitD, from either lack of substrate (VitD deficiency) and/or abnormal regulation of this system.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1529-2908
DOIs
StatusVeröffentlicht - 01.2022
Extern publiziertJa